The United States recently became the first country to approve a vaccine for pregnant women that prevents severe disease caused by respiratory syncytial virus (RSV) in their babies.
They were quickly followed by the European Union three days later, which also approved the drug for use in older adults.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
